MLYS R&D Expenses

Mineralys Therapeutics Inc · R&D Expenses

MLYS logo

MLYS R&D Expenses

Latest reported$301.59M
MLYS R&D Expenses ($2.41M → $301.59M)
High-resolution chart · PNG

MLYS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Mineralys Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
132,009,000
168,581,000
70,361,000
26,250,000
16,308,000
2,411,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.